HAVCR2 and hepatocellular carcinoma: The CD39 on macrophages and the CD73 on HCC cells cooperatively activate the adenosine pathway, thereby inhibiting the function of CD8+ T cells, as evidenced by reduced secretion of granzyme B and increased expression of PD-1 and TIM-3 [80].